CRISPR Therapeutics AG (NASDAQ:CRSP) traded at $150.07 at last check on Friday, 07/02/21, made a downward move of -3.73% on its previous day’s price.
Looking at the stock we see that its previous close was $155.88 with the day’s price range being $151.52 – $158.265. In terms of its 52-week price range, CRSP has a high of $220.20 and a low of $76.71. The company’s stock has gained about 41.93% over that past 30 days.
CRISPR Therapeutics AG has a market cap of $11.87 billion.
There have been no upward and no downward revisions for the stock’s EPS in last 7 days, something that reflects the nature of company’s price movement in short term. On the other hand, looking at the outlook for the CRSP stock, short term indicators assign the stock an average of 100% Buy, while medium term indicators assign it an average of 50% Sell. Long term indicators on average place the stock in the category of 50% Buy.
Based on estimates by 21 analysts, where scores have ranged from 1.00 for a strong buy to 5.00 for a strong sell, 6 have rated the CRISPR Therapeutics AG (CRSP) stock as a Hold, while 14 rate it as a Buy. 0 analyst(s) rate it as overweight while 0 of them rated it as underweight, whereas 1 suggest the stock as a Sell. The stock has an overall rating of Overweight and investors could take advantage and scoop up stock of the company.
Looking further, we note the current price level is 11.72% off its SMA20 and 21.64% from its 50-day simple moving average. The RSI (14) is pointing at 65.14 while the volatility over the past week is 7.74% and jumps to 5.24% over the past one month. The beta value is 2.27, while the average true range (ATR) is currently pointing at 7.61. The average price target for the stock over the next 12 months is $163.11, with the estimates having a low of $117.00 and a high of $220.00. These price ends are 22.04% and -46.6% off the today’s price level respectively, although investors could be excited at the prospect of a -9.95% if the CRSP share price touches on the median price of $165.00.
Let’s briefly compare CRISPR Therapeutics AG (CRSP) stock to its peers. We find that today’s price change of -3.73% and 95.58% over the past 12 months for CRSP competes that of Pieris Pharmaceuticals Inc. (PIRS), which has seen its stock price fall -1.37% in the latest trading session and is 19.61% over the last one year. . In contrast to these companies, both the S&P 500 Index and the Dow Jones Industrial are today at -0.73% and -1.05%, respectively, in early deals.
Coming back to CRISPR Therapeutics AG (NASDAQ:CRSP), we note that the average 3-month trading volume was 1.43 million. Current shares outstanding are 75.00 million.
The insiders hold 1.20% of the company’s shares while institutions hold 58.30%. Investors should be excited about this stock as its upside potential is great, with today’s price pushing the stock 1.81% up in year-to-date price movement.